Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 497-503

  Fulton, D ^b   Mcgiff, J C ^b   Quilley, J ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; ACETYLCHOLINE; ALCOHOL; BRADYKININ; CALCIUM; CALCIUM CHANNEL; CHARYBDOTOXIN; CLOTRIMAZOLE; CROMAKALIM; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXIDE; HEPARIN; IBERIOTOXIN; INDOMETACIN; N(G) NITROARGININE; NIFEDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PENTOBARBITAL; POTASSIUM CHANNEL; PROSTAGLANDIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; ENDOTHELIUM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; BRADYKININ; CALCIUM CHANNELS; CYTOCHROMES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEART; ION CHANNEL GATING; MALE; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 0032464621     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. + channels by cytochrome P450 inhibitors. J Biol Chem 267:11789-11793.
2. Bauersachs J, Hecker M and Busse R (1994) Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113:1548-1553.
3. Broadley, KJ (1979) The Langendorff heart preparation - reappraisal of its role as a research and teaching model for coronary vasoactive drugs. J Pharmacol Methods 2:143-156.
4. Campbell WB, Gebremedhin D, Pratt PF and Harder DR (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78:415-423.
5. Carroll MA, Garcia MP, Falck JR and McGiff JC (1990) 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ Res 67:1082-1088.
6. Ca channel opener in vascular smooth muscle. Br J Pharmacol 113:1538-1547.
7. Edwards G, Zygmunt PM, Hogestatt ED and Weston AH (1996) Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. Br J Pharmacol 119:691-701.
8. Fulton D, McGiff JC and Quilley J (1992) Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 107:722-725.
9. + channels in the vasodilator response to bradykinin in the rat heart. Br J Pharmacol 113:954-958.
10. + conductance. 9th International Conference on Prostaglandins and Related Compounds, Florence, Italy.
11. Fulton D, Mahboubi K, McGiff JC and Quilley J (1995) Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol 114:99-102.
12. 2 in the nitric oxide independent vasodilator effect of bradykinin in the rat perfused heart. J Pharmacol Exp Ther 278:518-526.
13. Holland M, Langton PD, Standen NB and Boyle JP (1996) Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 117:119-129.
14. Kuriyama H, Kitamura K and Nabata H (1995) Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev 47:391-573.
15. Langendorff O (1895) Untersurchargen am iiberlebender Saugethierherzer. Pflugers Arch Ces Physiol 61:295-303.
16. Laurent F, Michel A, Bonnet PA, Chapat JP and Boucard M (1993) Evaluation of the relaxant effects of SCA 40, a novel charybdotoxin-sensitive potassium channel opener, in guinea pig isolated trachealis. Br J Pharmacol 108:622-626.
17. McGiff JC (1991) Cytochrome-P450 metabolism of arachidonic acid. Ann Rev Pharmacol Toxicol 31:339-369.
18. + channel. JPET 285:659-664.
19. Oyekan AO, McGiff JC, Rosencrantz-Weiss P and Quilley J (1994) Relaxant responses of rabbit aorta: Influence of cytochrome P450 inhibitors. JPET 268:262-269.
20. Popp R, Bauersachs J, Hecker M, Fleming I and Busse R (1996) A transferable, β-naphthaflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol 497:699-709.
21. Quilley J, Fulton D and McGiff JC (1994) The position of NO among endogenous vasodilators. Pol J Pharmacol 46:523-530.
22. Rapacon M, Mieyal P, McGiff JC, Fulton D and Quilley J (1996) Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated perfused kidney of the rat. Br J Pharmacol 118:1504-1508.
23. Revest PA and Abbott NJ (1992) Membrane ion channels of endothelial cells. Trends Pharmacol Sci 13:404-407.
24. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 264:H327-H335.
25. Taylor SG and Westen AH (1988) Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 9:272-274.
26. 2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J 6:2742-2747.
27. + channel activity. Am J Physiol 270:F822-F832.